LMOD1 Loss Triggers Rapid Atherosclerosis. 08/05/26

Welcome to Cardiology Today – Recorded August 05, 2026. This episode summarizes 5 key cardiology studies on topics like gene knockout and genetic predictors. Key takeaway: LMOD1 Loss Triggers Rapid Atherosclerosis.. Article Links: Article 1: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. (Circulation) Article 2: Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. (Circulation) Article 3: COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. (Circulation) Article 4: Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. (Circulation) Article 5: Side effects in hypertension treatment: a pharmacogenomic analysis. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/lmod1-loss-triggers-rapid-atherosclerosis-08-05-26/ Featured Articles Article 1: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549517 Summary: This COMBINE-AF analysis identified extracranial bleeding as the most common complication of oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation. Researchers characterized these bleeding events according to standardized severity definitions. The study identified baseline risk factors for bleeding and quantified their population attributable fraction in patients receiving oral anticoagulants. Article 2: Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549514 Summary: This study found that the protein LAPTM4A facilitates autophagosome-lysosome fusion. This specific mechanism attenuates myocardial ischemia-reperfusion injury, which otherwise leads to functional impairment and structural damage in the heart. The findings demonstrate LAPTM4A as a novel strategy to limit damage caused by myocardial ischemia-reperfusion injury, addressing a critical unmet clinical need. Article 3: COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549511 Summary: This research demonstrated that the interaction between COL1A1 and CD44/SLC7A11 enhances cystine uptake. This specific process results in the accumulation of CD34 positive foam-like macrophages in transplant arteriosclerosis. These findings elucidate key regulatory mechanisms of macrophages in allograft arteriosclerosis, offering a foundation for developing targeted therapies against chronic transplant arteriosclerosis, a primary cause of long-term graft failure. Article 4: Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549503 Summary: This study found that the loss of the Coronary Artery Disease risk gene LMOD1 specifically in vascular smooth muscle cells triggers rapid-onset coronary atherosclerosis. The results establish LMOD1 as a critical regulator in vascular smooth muscle cell function. This finding reveals a previously unknown role for LMOD1 in coronary artery pathophysiology and the development of atherosclerosis. Article 5: Side effects in hypertension treatment: a pharmacogenomic analysis. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42545033 Summary: This extensive pharmacogenomic analysis classified short-term antihypertensive medication use trajectories from over 400000 genotyped users across three cohorts. The study addressed the challenge that up to half of patients switch or discontinue antihypertensive medications within the first year due to elusive underlying mechanisms. This large-scale analysis provided a framework for investigating genetic influences on these medication patterns. Transcript Today’s date is August 05, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. This COMBINE-AF analysis identified extracranial bleeding as the most common complication of oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation. Researchers characterized these bleeding events according to standardized severity definitions. The study identified baseline risk factors for bleeding and quantified their population attributable fraction in patients receiving oral anticoagulants. Article number two. Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. This study found that the protein LAPTM4A facilitates autophagosome-lysosome fusion. This specific mechanism attenuates myocardial ischemia-reperfusion injury, which otherwise leads to functional impairment and structural damage in the heart. The findings demonstrate LAPTM4A as a novel strategy to limit damage caused by myocardial ischemia-reperfusion injury, addressing a critical unmet clinical need. Article number three. COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. This research demonstrated that the interaction between COL1A1 and CD44/SLC7A11 enhances cystine uptake. This specific process results in the accumulation of CD34 positive foam-like macrophages in transplant arteriosclerosis. These findings elucidate key regulatory mechanisms of macrophages in allograft arteriosclerosis, offering a foundation for developing targeted therapies against chronic transplant arteriosclerosis, a primary cause of long-term graft failure. Article number four. Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. This study found that the loss of the Coronary Artery Disease risk gene LMOD1 specifically in vascular smooth muscle cells triggers rapid-onset coronary atherosclerosis. The results establish LMOD1 as a critical regulator in vascular smooth muscle cell function. This finding reveals a previously unknown role for LMOD1 in coronary artery pathophysiology and the development of atherosclerosis. Article number five. Side effects in hypertension treatment: a pharmacogenomic analysis. This extensive pharmacogenomic analysis classified short-term antihypertensive medication use trajectories from over 400000 genotyped users across three cohorts. The study addressed the challenge that up to half of patients switch or discontinue antihypertensive medications within the first year due to elusive underlying mechanisms. This large-scale analysis provided a framework for investigating genetic influences on these medication patterns. Thank you for listening. Don’t forget to subscribe. Keywords gene knockout, genetic predictors, graft failure, therapeutic strategy, bleeding risk factors, LAPTM4A, extracranial bleeding, LMOD1, CD34 positive macrophages, macrophage accumulation, vascular smooth muscle cells, cardiac damage, COL1A1, stroke prevention, myocardial ischemia-reperfusion injury, pharmacogenomics, hypertension, oral anticoagulants, atherosclerosis, autophagosome-lysosome fusion, antihypertensive medications, medication adherence, transplant arteriosclerosis, atrial fibrillation, coronary artery disease. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post LMOD1 Loss Triggers Rapid Atherosclerosis. 08/05/26 first appeared on Cardiology Today.